DiaSorin S.p.A. (DSRLF)
Company Description
DiaSorin S.p.A. develops, manufactures, and distributes immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China.
The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIAISON XL, and LIAISON XL LAS; and molecular diagnostics platform comprising of LIAISON MDX for use in the amplification of nucleic acids to diagnose viral infections through the identification of virus in patient's biological sample.
It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections.
The company was founded in 1968 and is headquartered in Saluggia, Italy.
| Country | IT |
| IPO Date | Sep 11, 2009 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 3,249 |
| CEO | Carlo Rosa |
Contact Details
Address: Via Crescentino snc Saluggia, VC IT | |
| Website | https://diasoringroup.com |
Stock Details
| Ticker Symbol | DSRLF |
| Exchange | PNK |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | IT0003492391 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Carlo Rosa | Chief Executive Officer, GM & Executive Director |
| Piergiorgio Pedron | Senior Corporate Vice President, Chief Financial Officer & Corporate Accounting Documents Officer |
| Amelia Parente | Senior Corporate Vice President of Human Resources |
| Angelo Rago | President of Luminex Corporation |
| Dr. Chen Menachem Even | Chief Commercial Officer, Senior Corporate Vice President of Commercial Operations & Executive Director |
| Dr. Riccardo Fava | Corporate Vice President of Communication, ESG & Investor Relations |
| Ulisse Spada | Corporate Vice President, Head of the Legal Department, Secretary & General Counsel |